Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
Crossref DOI link: https://doi.org/10.1038/s41598-021-99827-3
Published Online: 2021-10-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laurini, Erik
Marson, Domenico
Aulic, Suzana
Fermeglia, Alice
Pricl, Sabrina
Text and Data Mining valid from 2021-10-12
Version of Record valid from 2021-10-12
Article History
Received: 13 July 2021
Accepted: 30 September 2021
First Online: 12 October 2021
Competing interests
: The authors declare no competing interests.